Matthew R. Kwietniak, Chief Commercial Officer at Avid Bioservices, Inc. (CDMO), sold 119 shares at $8.05 ($958) on 2024-07-12, disclosed to the SEC on 2024-07-15.
Open-market sale of $958 CDMO by Chief Commercial Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| CDMO | SELL | 2024-10-11 | $10K | — | Filing → |
| CDMO | SELL | 2024-07-16 | $3K | — | Filing → |
| CDMO | SELL | 2024-07-11 | $3K | — | Filing → |